Global Biomarkers Research Report 2019: Technologies,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
10
Global Biomarkers Research Report 2019: Technologies, Markets & Companies 2018-2028 with Profiles of 300+ Companies

Dublin, Feb. 07, 2019 (GLOBE NEWSWIRE) -- The "Biomarkers - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention.

Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.

Currently the most important applications of biomarkers are in drug discovery and development. The role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described. Biomarkers are useful not only for diagnosis of some of these diseases but also for understanding the pathomechanism as well as a basis for development of therapeutics.

Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine.

Many of the regulatory issues concerning biomarkers are related to genomics, proteomics, molecular diagnostics and pharmacogenomics/pharmacogenetics. Validation of biomarkers and their role in clinical trials is discussed.

Biomarker markets are estimated from 2018 to 2028 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics. Market values are further split according to therapeutic applications and major geographical areas. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarker markets. Challenges facing the biomarker industry and strategies for developing biomarker markets are discussed.

A large number of companies with varying technical backgrounds are involved in biomarkers and 301 of these are profiled in part 2 of the report with classification into various categories.These also include major pharmaceutical companies. There is tabulation of 471 collaborations between companies and additional academic collaborations are mentioned in the individual profiles of companies. The report is supplemented by 1000 references, 81 tables and 23 figures.

Key Topics Covered:

Part 1: Technologies & Applications Executive Summary 1. Introduction 2. Technologies for Discovery of Biomarkers 3. Biomarkers and Molecular Diagnostics 4. Biomarkers for Drug Discovery & Development 5. Role of Biomarkers in Healthcare 6. Biomarkers in Metabolic Disorders 7. Biomarkers in Immune Disorders 8. Biomarkers of Musculoskeletal Disorders 9. Biomarkers of Infectious Diseases 10. Biomarkers of Genetic Disorders 11. Biomarkers of Aging 12. Nutritional Biomarkers 13. Biomarkers of Cancer 14. Biomarkers of Disorders of the Nervous System 15. Biomarkers of Cardiovascular Disorders 16. Biomarkers of Pulmonary Diseases 17. Biomarkers in Gynecology and Obstetrics 18. Biomarkers & Personalized Medicine 19. Biomarkers and Regulatory issues 20. References Part II: Markets & Companies 21. Markets for Biomarkers 22. Companies

For more information about this report visit https://www.researchandmarkets.com/research/h...rkers?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomarkers

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 328

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 214

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Transocean Ltd. Scheduled Earnings Conference Call for Q3 2024

Updated Category News Views 52

Transocean Ltd. Earnings Release Announcement Transocean Ltd. has officially announced that it will be releasing its third quarter earnings for 2024. The earnings report is scheduled for Wednesday, October 30, 2024. This release is highly anticipated as it aims to provide stakeholders with insights regarding the company's performance in the offshore contract drilling...

Continue Reading
Stride, Inc. Faces Class Action as Investors Seek Justice

Updated Category News Views 151

Stride, Inc. Faces Securities Lawsuit Stride, Inc. (NYSE: LRN), a prominent educational service provider, finds itself embroiled in a class action lawsuit alleging serious violations of securities laws. Investors who feel wronged are encouraged to engage with experienced legal counsel to explore their options. The law firm Levi & Korsinsky, known for its adept handling of...

Continue Reading
Amazon's Prime Day and Golden Cross: A Bullish Outlook

Updated Category News Views 185

Amazon's Market Dynamics and Performance Insights In today's ever-evolving technology sector, companies often evaluate key performance indicators (KPIs) that forecast their future success. Amazon.com (NASDAQ: AMZN) exemplifies this, boasting a market capitalization of $2.3 trillion. Each year, Amazon's Prime Day is a highlight for online shoppers, offering discounts that...

Continue Reading
Previewing Lam Research's Upcoming Earnings Release

Updated Category News Views 152

Preparing for Lam Research's Earnings Announcement Lam Research (NASDAQ:LRCX) is gearing up for its next quarterly earnings report. Investors are anxious for an update, especially with anticipation building around the company’s performance. Understanding the upcoming earnings can provide crucial insights into Lam Research’s potential growth trajectory. What Analysts...

Continue Reading
AAR CORP. Announces Public Offering of 3 Million Shares

Updated Category News Views 272

AAR CORP. Pricing of Public Offering AAR CORP. ('AAR' or the 'Company') (NYSE: AIR) has officially announced the pricing of a significant underwritten public offering encompassing 3,000,000 shares of its common stock. The shares are being offered at a set price of $83.00 per share, with the underwriters given a 30-day option to acquire an extra 450,000 shares from AAR at...

Continue Reading